Results 51 to 60 of about 5,142 (211)

A 37-year-old woman presenting with impaired visual function during antituberculosis drug therapy: a case report [PDF]

open access: yes, 2011
Introduction Combination antituberculosis drug therapy remains the mainstay of treating tuberculosis. Unfortunately, antituberculosis drugs produce side effects including (toxic) impaired visual function, which may be irreversible.
Abdulkabir A Ayanniyi   +1 more
core   +1 more source

Endoscopic Orbital Decompression for Graves’ Orbitopathy – A Vietnam Study

open access: yesClinical Ophthalmology, 2021
Thi My Hanh Pham,1,2 Chien Thang Nguyen,1 Quoc Tung Mai,2 Thi Huong Giang Bui,2 Dung Hoa Do,2 Peter McCluskey,3 Trong Van Pham2 1Department of Ophthalmology, 103 Military Hospital, Hanoi, Vietnam; 2Department of Ophthalmology, Hanoi Medical University ...
Pham TMH   +6 more
doaj  

Non-glaucomatous Optic Disc Cupping: A Brief Review [PDF]

open access: yesCaspian Journal of Neurological Sciences, 2023
Although optic disc cupping is mostly seen in glaucoma patients, it can occur in non-glaucomatous optic neuropathies (NGON). The characteristics of NGON are cupping toxic optic neuropathies, optic neuritis, compressive ischemia, and hereditary nature ...
Hassan Behboudi, Ebrahim Azaripour
doaj  

Delayed Nonarteritic Posterior Ischemic Optic Neuropathy following Herpes Zoster Ophthalmicus: A Case Report

open access: yesCase Reports in Neurology, 2023
Posterior ischemic optic neuropathy (PION), a relatively rare condition, is diagnosed primarily based on the clinical presentation of sudden visual impairment, an optic nerve-related visual field defect, and an initial normal optic disc that corresponds ...
Cheng-En Wu   +2 more
doaj   +1 more source

Choroidal Thickness in Nonarteritic Anterior Ischaemic Optic Neuropathy: A Study with Optical Coherence Tomography [PDF]

open access: yes, 2014
Nonarteritic anterior ischemic optic neuropathy (NA-AION) is the most common nonglaucomatous optic neuropathy in adults over 50 years of age. It is usually related to cardiovascular risk factors.
Abegão Pinto, L   +7 more
core   +1 more source

To study visual evoked potential in patients with optic nerve diseases

open access: yesJournal of Clinical Ophthalmology and Research
Background: To study Visual Evoked Potential in patients with Optic Nerve diseases. Study design and settings: Cross – Sectional study. Material and Methods: 72 patients were included in our study, aged 12 years and above, diagnosed as optic nerve ...
Kavita Poonia   +3 more
doaj   +1 more source

Patients With Normal Tension Glaucoma Have Relative Sparing of the Relative Afferent Pupillary Defect Compared to Those With Open Angle Glaucoma and Elevated Intraocular Pressure [PDF]

open access: yes, 2017
PURPOSE: We determined whether there is relative sparing of pupil function in glaucoma patients with normal pressures compared to those with high pressures. METHODS: A cross-sectional study was done of 68 patients with primary open angle glaucoma (POAG):
Bunce, C   +6 more
core   +1 more source

Clinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjögren's Disease

open access: yesArthritis Care &Research, EarlyView.
Objective Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.
Anahita Deboo   +88 more
wiley   +1 more source

OPA1 analysis in an international series of probands with bilateral optic atrophy [PDF]

open access: yes, 2017
Purpose To determine the molecular genetic cause in previously unreported probands with optic atrophy from the United Kingdom, Czech Republic and Canada.
Adzhubei   +59 more
core   +1 more source

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

open access: yesArthritis &Rheumatology, EarlyView.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

Home - About - Disclaimer - Privacy